financetom
Business
financetom
/
Business
/
Birkenstock raises fiscal 2025 revenue forecast
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Birkenstock raises fiscal 2025 revenue forecast
Sep 25, 2025 12:24 AM

(Reuters) -German sandal maker Birkenstock ( BIRK ) on Thursday forecast fiscal 2025 revenue of at least 2.09 billion euros ($2.45 billion) on strong demand for its clogs and shoes, ahead of its prior guidance.

The company had previously said it expects full-year revenue growth at the higher end of its forecast range of 15% to 17%.

($1 = 0.8514 euros)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
US licenses for Trinidad-Venezuela gas projects revoked, Trinidad says
US licenses for Trinidad-Venezuela gas projects revoked, Trinidad says
Apr 8, 2025
April 8 (Reuters) - The United States has revoked two licenses it had granted in recent years for the development of offshore natural gas projects between Trinidad and Tobago and Venezuela, the Caribbean country's prime minister, Stuart Young, said on Tuesday. The authorizations, which have allowed Shell, BP and Trinidad's National Gas Company to plan the projects, now have a...
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Annexon Cites 'Durable Benefit' of Tanruprubart in Guillain-Barre Syndrome Trial
Annexon Cites 'Durable Benefit' of Tanruprubart in Guillain-Barre Syndrome Trial
Apr 8, 2025
05:15 PM EDT, 04/08/2025 (MT Newswires) -- Annexon ( ANNX ) reported rapid recovery and durable benefit for patients in the phase 3 trial of tanruprubart, a potential targeted therapy for Guillain-Barre Syndrome, The trial showed a 2.4-fold higher likelihood of improvement at week eight versus placebo in 241 patients, the company said Tuesday in a statement, with the results...
Market Chatter: KKR Finalizing Terms to Buy Karo Healthcare in $2.7 Billion Deal
Market Chatter: KKR Finalizing Terms to Buy Karo Healthcare in $2.7 Billion Deal
Apr 8, 2025
05:19 PM EDT, 04/08/2025 (MT Newswires) -- KKR (KKR) is finalizing terms to acquire EQT AB-backed Karo Healthcare in a transaction that could value the Sweden-based consumer health firm at more than 2.5 billion euros ($2.7 billion), Bloomberg reported Tuesday, citing people familiar with the matter. Talks are in the final stages but could still be postponed or called off,...
Copyright 2023-2026 - www.financetom.com All Rights Reserved